MAQUET CARDIOPULMONARY GMBH

Manufacturer adverse-event records for MAQUET CARDIOPULMONARY GMBH come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2014–2026 · thin-book · elevated Death-code · injury-light

Death-code intensity

MAQUET CARDIOPULMONARY GMBH carries an elevated Death-code share

Death-coded event_type rows are 338 of 4,424 (7.64% · elevated tercile among 434 manufacturers). Absolute volume is thin-book.

What the Death-code reading shows for MAQUET CARDIOPULMONARY GMBH

The standout signal for MAQUET CARDIOPULMONARY GMBH is Death-code intensity: 7.64% of 4,424 reports (elevated tercile), while absolute volume is thin-book.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 16 device types, led in this extract by Malfunction at 3,906 (88.3% of event_type total). Peak single-year volume reaches 707 reports across 11 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,424
Total Reports
338
Event-type Death
180
Injury Reports
16
Device Types

Event Types

Malfunction 3,906 (88.3%)
Death 338 (7.6%)
Injury 180 (4.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

3,382 (75.2%)
Required Intervention 398 (8.8%)
Death 322 (7.2%)
Other 200 (4.4%)
Life Threatening 88 (2.0%)
R 61 (1.4%)
L 28 (0.6%)
D 9 (0.2%)
O 9 (0.2%)
Hospitalization 2 (0.0%)
H 1 (0.0%)

Yearly Trend

14
2014: 2
15
2015: 3
16
2016: 1
19
2019: 331
20
2020: 461
21
2021: 707
22
2022: 563
23
2023: 694
24
2024: 642
25
2025: 619
26
2026: 401